LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY

被引：0
|
作者：
Lim, F. L. [1 ]
Shamash, J. [2 ]
Wilson, P. [2 ]
Powles, T. [3 ]
机构：
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
[2] Barts Canc Insititute, QMUL, London, England
[3] St Bartholomews Hosp QMUL, Barts Canc Inst, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [41] Brain metastases in patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC)
    Alharbi, H.
    Choueiri, T. K.
    Kollmannsberger, C. K.
    North, S.
    MacKenzie, M. J.
    Knox, J. J.
    Rini, B. I.
    Heng, D. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [42] Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
    You, Dalsan
    Lee, Chunwoo
    Jeong, In Gab
    Song, Cheryn
    Lee, Jae-Lyun
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (11) : 2331 - 2338
  • [43] Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy
    Takagi, Toshio
    Yoshida, Kazuhiko
    Kondo, Tsunenori
    Fukuda, Hironori
    Ishihara, Hiroki
    Kobayashi, Hirohito
    Iizuka, Junpei
    Ishida, Hideki
    Tanabe, Kazunari
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1744 - 1750
  • [44] Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
    Dalsan You
    Chunwoo Lee
    In Gab Jeong
    Cheryn Song
    Jae-Lyun Lee
    Bumsik Hong
    Jun Hyuk Hong
    Hanjong Ahn
    Choung-Soo Kim
    [J]. Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2331 - 2338
  • [45] Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma
    Santoni, Matteo
    Conti, Alessandro
    Porta, Camillo
    Procopio, Giuseppe
    Sternberg, Cora N.
    Basso, Umberto
    De Giorgi, Ugo
    Bracarda, Sergio
    Rizzo, Mimma
    Ortega, Cinzia
    Massari, Francesco
    Iacovelli, Roberto
    Derosa, Lisa
    Masini, Cristina
    Milella, Michele
    Di Lorenzo, Giuseppe
    Atzori, Francesco
    Pagano, Maria
    Buti, Sebastiano
    De Vivo, Rocco
    Mosca, Alessandra
    Rossi, Marta
    Paglino, Chiara
    Verzoni, Elena
    Cerbone, Linda
    Muzzonigro, Giovanni
    Falconi, Massimo
    Montironi, Rodolfo
    Burattini, Luciano
    Santini, Daniele
    Cascinu, Stefano
    [J]. JOURNAL OF UROLOGY, 2015, 193 (01): : 41 - 47
  • [46] Starting with low dose pazopanib in the treatment of Japanese patients with metastatic renal cell carcinoma
    Akatsuka, J.
    Kimura, G.
    Shibayama, K.
    Sano, M.
    Endo, Y.
    Takeda, H.
    Hamasaki, T.
    Kondo, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [47] Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
    Poprach, Alexandr
    Fiala, Ondrej
    Chloupkova, Renata
    Melichar, Bohuslav
    Lakomy, Radek
    Petrakova, Katarina
    Zemanova, Milada
    Kopeckova, Katerina
    Slaby, Ondrej
    Studentova, Hana
    Kopecky, Jindrich
    Kiss, Igor
    Finek, Jindrich
    Dusek, Ladislav
    Buchler, Tomas
    [J]. ANTICANCER RESEARCH, 2018, 38 (01) : 449 - 456
  • [48] Prospective evaluation of circulating cell-free DNA sequencing in patients with metastatic renal cell carcinoma treated with pazopanib plus abexinostat
    Leng, Jim
    Harb, Armand
    Abri, Kamran
    Mastroserio, Ilaria
    Reinert, Anne
    Grabowsky, Jennifer A.
    Ryan, Charles J.
    Friedlander, Terence W.
    Lin, Amy M.
    Lanman, Richard Burnham
    Banks, Kimberly C.
    Aggarwal, Rahul Raj
    Munster, Pamela N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies
    Matrana, M. R.
    Duran, C.
    Shetty, A.
    Xiao, L.
    Atkinson, B. J.
    Corn, P.
    Pagliaro, L. C.
    Millikan, R. E.
    Charnsangave, C.
    Jonasch, E.
    Tannir, N. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3169 - 3175
  • [50] Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Gupta, Shiva
    Kang, Hyunseon C.
    Sun, Jia
    Matrana, Marc R.
    Tannir, Nizar M.
    Choi, Haesun
    [J]. ABDOMINAL RADIOLOGY, 2020, 45 (06) : 1872 - 1882
12345